In this respect, low CD166 expression was associated with higher pT (p = 0.014), an infiltrating growth pattern (p = 0.002) and reduced survival (p = 0.019) in a study performed on 1420 primary CRC cases [68]. Here, ALCAM is linked to colorectal carcinoma.